Literature DB >> 9880302

Other method for adjustment of multiple testing exists.

M Aickin.   

Abstract

Mesh:

Year:  1999        PMID: 9880302      PMCID: PMC1114591          DOI: 10.1136/bmj.318.7176.127a

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  2 in total

1.  Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods.

Authors:  M Aickin; H Gensler
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

Review 2.  What's wrong with Bonferroni adjustments.

Authors:  T V Perneger
Journal:  BMJ       Date:  1998-04-18
  2 in total
  10 in total

1.  Adjusting for multiple testing in studies is less important than other concerns.

Authors:  T V Perneger
Journal:  BMJ       Date:  1999-05-08

2.  The statistical analysis of immunohaematological data.

Authors:  Roberto Reverberi
Journal:  Blood Transfus       Date:  2008-01       Impact factor: 3.443

3.  Developmental prosopagnosics have widespread selectivity reductions across category-selective visual cortex.

Authors:  Guo Jiahui; Hua Yang; Bradley Duchaine
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

4.  Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations.

Authors:  Rudi Hwang; Takahiro Shinkai; Vincenzo De Luca; Daniel J Müller; Xingqun Ni; Fabio Macciardi; Steven Potkin; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

5.  Habitual physical activity and health-related quality of life in older adults: interactions between the amount and intensity of activity (the Nakanojo Study).

Authors:  Yukitoshi Aoyagi; Hyuntae Park; Sungjin Park; Roy J Shephard
Journal:  Qual Life Res       Date:  2010-04       Impact factor: 4.147

6.  HTR2A A-1438G/T102C polymorphisms predict negative symptoms performance upon aripiprazole treatment in schizophrenic patients.

Authors:  Shih-Fen Chen; Yu-Chih Shen; Chia-Hsiang Chen
Journal:  Psychopharmacology (Berl)       Date:  2009-04-23       Impact factor: 4.530

7.  Closed Testing in Pharmaceutical Research: Historical and Recent Developments.

Authors:  Kevin S S Henning; Peter H Westfall
Journal:  Stat Biopharm Res       Date:  2015       Impact factor: 1.452

8.  Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response.

Authors:  Renan P Souza; Marco A Romano-Silva; Jeffrey A Lieberman; Herbert Y Meltzer; Albert H C Wong; James L Kennedy
Journal:  Psychopharmacology (Berl)       Date:  2008-05-26       Impact factor: 4.530

9.  A method to compute multiplicity corrected confidence intervals for odds ratios and other relative effect estimates.

Authors:  Jimmy Thomas Efird; Susan Searles Nielsen
Journal:  Int J Environ Res Public Health       Date:  2008-12       Impact factor: 3.390

10.  Electrophysiological responses to images ranging in motivational salience: Attentional abnormalities associated with schizophrenia-spectrum disorder risk.

Authors:  Elizabeth A Martin; Lilian Yanqing Li; Mayan K Castro
Journal:  Sci Rep       Date:  2020-03-12       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.